News
Sixty seconds on . . . semaglutide
BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j5010 (Published 01 November 2017) Cite this as: BMJ 2017;359:j5010
- Nigel Hawkes
- London
A drug that treats diabetes and cuts weight?
So it seems. A study of 28 obese people in Leeds found that they lost an average of 5 kg and cut food intake by nearly a quarter when treated with semaglutide, an antidiabetes drug being developed by Novo Nordisk.1
But that’s a tiny trial
There are lots more data. Documents submitted to the US Food and Drug Administration by the company show …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.